Xuefeng Yu

Chairman and CEO, CanSino Biologics
· tracked since Aug 2026
Calls
1
Win Rate
0.0%
return
-11.1%
Calls 1 1 Posts tracked · 0.1/day
Calls
7d 0
30d 1
90d 1
Best Calls
No live winners yet
Worst Calls
CANSF Long -11.1%
Most Mentioned
CANSF ×1
Recent Calls
CANSF Long 1 week ago
Win Rate 0% Long 1 Short 0
Win Rate
7d —
30d —
90d —
Average Return -11.1% Long Return -11.1% Short Return -
Average Return
7d —
30d —
90d —
Loading charts...
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
CANSF CanSino ... CanSino Biologics Inc.
Long
Aug 28
$0.09
-11.1%
Vaccine sales and mRNA pipeline drive growth.
CanSino Biologics is transitioning to profitability with strong revenue growth driven by its meningococcal and pneumococcal conjugate vaccines, significant international market expansion, and a promising mRNA pipeline for cancer therapeutics.
Pharma & Biotech
YOUTUBE
Showing 1 of 1 calls · sorted by mentions

Xuefeng Yu has 1 trade ideas tracked on Buzzberg across 1 tickers since August 2026. Most covered: CANSF.